LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 41

Search options

  1. Article ; Online: Identifying cancer patients at risk for cardiotoxicity.

    Salvatici, Michela / Sandri, Maria T

    Future oncology (London, England)

    2015  Volume 11, Issue 14, Page(s) 2077–2091

    Abstract: Improvements in therapies have significantly changed survival of cancer patients. However, the clinical history and oncologic treatment put cancer patients at higher risk for developing cardiovascular problems. Anthracyclines, but also the targeted ... ...

    Abstract Improvements in therapies have significantly changed survival of cancer patients. However, the clinical history and oncologic treatment put cancer patients at higher risk for developing cardiovascular problems. Anthracyclines, but also the targeted therapy and angiogenesis inhibitors, are all treatments associated with cardiotoxicity. The most common adverse event is a reduction in left ventricular ejection fraction that may progress to overt heart failure. Recognition of a cardiac impairment during or after a potential cardiotoxic treatment requires a stringent assessment of clinical symptoms and signs of heart failure associated with an evaluation of the left ventricular ejection fraction, which, however, detects the damage already installed. Circulating cardiac biomarkers are promising in detecting cardiotoxicity and will likely change the approach for identifying patients at risk.
    MeSH term(s) Antineoplastic Agents/adverse effects ; Biomarkers/blood ; Cardiac Imaging Techniques ; Cardiotoxicity/diagnosis ; Cardiotoxicity/etiology ; Cardiotoxicity/genetics ; Female ; Galectin 3/blood ; Genetic Predisposition to Disease ; Humans ; Male ; Natriuretic Peptides/blood ; Neoplasms/complications ; Neoplasms/drug therapy ; Neoplasms/mortality ; Precision Medicine ; Risk Factors ; Troponin T/blood ; Ventricular Dysfunction, Left/chemically induced ; Ventricular Dysfunction, Left/etiology
    Chemical Substances Antineoplastic Agents ; Biomarkers ; Galectin 3 ; LGALS3 protein, human ; Natriuretic Peptides ; Troponin T
    Language English
    Publishing date 2015-07-07
    Publishing country England
    Document type Journal Article ; Review
    ZDB-ID 2274956-1
    ISSN 1744-8301 ; 1479-6694
    ISSN (online) 1744-8301
    ISSN 1479-6694
    DOI 10.2217/fon.15.69
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article ; Online: Effect of manual, preloaded, and automated preloaded injectors on corneal incision architecture after IOL implantation.

    Cennamo, Michela / Favuzza, Eleonora / Salvatici, Maria Cristina / Giuranno, Gabriele / Buzzi, Matilde / Mencucci, Rita

    Journal of cataract and refractive surgery

    2020  Volume 46, Issue 10, Page(s) 1374–1380

    Abstract: Purpose: To analyze the effects on corneal morphology of manual, preloaded, and automated preloaded intraocular lens (IOL) injectors in eye bank human corneas by environmental scanning electron microscopy (ESEM) and in patients after phacoemulsification ...

    Abstract Purpose: To analyze the effects on corneal morphology of manual, preloaded, and automated preloaded intraocular lens (IOL) injectors in eye bank human corneas by environmental scanning electron microscopy (ESEM) and in patients after phacoemulsification using anterior segment optical coherence tomography (AS-OCT).
    Settings: Eye Clinic, Careggi University Hospital, Florence, Italy.
    Design: Retrospective and experimental study.
    Methods: Seventy-eight corneal incisions were examined after IOL implantation: 30 in human corneas mounted on an artificial chamber using ESEM (ex vivo); 48 in patients undergoing phacoemulsification (in vivo). Three different injectors were used for both analyses: manual (Monarch III, n = 26), manual preloaded (UltraSert, n = 26), and automated preloaded system (AutonoMe, n = 26). Thirty IOLs were implanted in the ex vivo study: 5 intermediate and 5 high dioptric powers for AcrySof IQ (Monarch and UltraSert) and for Clareon (AutonoMe) IOLs. In the in vivo analysis, 16 corneal wounds for each injector were evaluated using AS-OCT; in the ex vivo study, incision width was measured and Descemet membrane detachment, posterior wound retraction, and posterior gape were analyzed.
    Results: In the eye bank corneas, the incision width was significantly wider in the high dioptric power IOL manual subgroup (P < .05), with more Descemet tearing compared with AutonoMe. In the in vivo study, the incidence of Descemet membrane detachment, posterior gape, and wound retraction was lower in the automated preloaded group at 1 postoperative day 1.
    Conclusions: The automated preloaded injector ensured less trauma to the wound and contributed to preserving the endothelial side of the incision even during the implantation of high-power IOLs and in the early postoperative period.
    Language English
    Publishing date 2020-07-09
    Publishing country United States
    Document type Journal Article
    ZDB-ID 632744-8
    ISSN 1873-4502 ; 0886-3350
    ISSN (online) 1873-4502
    ISSN 0886-3350
    DOI 10.1097/j.jcrs.0000000000000295
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article ; Online: Association between cardiac troponin I and mortality in patients with COVID-19.

    Salvatici, Michela / Barbieri, Barbara / Cioffi, Sara Maria Giulia / Morenghi, Emanuela / Leone, Francesco Paolo / Maura, Federica / Moriello, Giuseppe / Sandri, Maria Teresa

    Biomarkers : biochemical indicators of exposure, response, and susceptibility to chemicals

    2020  Volume 25, Issue 8, Page(s) 634–640

    Abstract: Background: Severe pneumonia is pathological manifestation of Coronavirus Disease 2019 (COVID-19), however complications have been reported in COVID-19 patients with a worst prognosis. Aim of this study was to evaluate the role of high sensitivity ... ...

    Abstract Background: Severe pneumonia is pathological manifestation of Coronavirus Disease 2019 (COVID-19), however complications have been reported in COVID-19 patients with a worst prognosis. Aim of this study was to evaluate the role of high sensitivity cardiac troponin I (hs-TnI) in patients with SARS-CoV-2 infection.
    Methods: we retrospectively analysed hs-TnI values measured in 523 patients (median age 64 years, 68% men) admitted to a university hospital in Milan, Italy, and diagnosed COVID-19.
    Results: A significant difference in hs-TnI concentrations was found between deceased patients (98 patients) vs discharged (425 patients) [36.05 ng/L IQR 16.5-94.9 vs 6.3 ng/L IQR 2.6-13.9,
    Conclusion: Increase of hs-TnI associated with elevated mortality in patients with COVID-19. Troponin shows to be a useful biomarker of disease progression and worse prognosis in COVID-19 patients.
    MeSH term(s) Aged ; Aged, 80 and over ; Biomarkers/blood ; COVID-19/blood ; COVID-19/epidemiology ; COVID-19/virology ; Female ; Heart Failure/blood ; Heart Failure/diagnosis ; Hospitalization/statistics & numerical data ; Humans ; Male ; Middle Aged ; Pandemics ; ROC Curve ; Retrospective Studies ; Risk Assessment/methods ; Risk Assessment/statistics & numerical data ; Risk Factors ; SARS-CoV-2/physiology ; Troponin I/blood
    Chemical Substances Biomarkers ; Troponin I
    Keywords covid19
    Language English
    Publishing date 2020-11-24
    Publishing country England
    Document type Journal Article
    ZDB-ID 1324372-x
    ISSN 1366-5804 ; 1354-750X
    ISSN (online) 1366-5804
    ISSN 1354-750X
    DOI 10.1080/1354750X.2020.1831609
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article ; Online: The antibody response to SARS-CoV-2 infection persists over at least 8 months in symptomatic patients.

    Levi, Riccardo / Ubaldi, Leonardo / Pozzi, Chiara / Angelotti, Giovanni / Sandri, Maria Teresa / Azzolini, Elena / Salvatici, Michela / Savevski, Victor / Mantovani, Alberto / Rescigno, Maria

    Communications medicine

    2021  Volume 1, Issue 1, Page(s) 32

    Abstract: Background: Persistence of antibodies to SARS-CoV-2 viral infection may depend on several factors and may be related to the severity of disease or to the different symptoms.: Methods: We evaluated the antibody response to SARS-CoV-2 in personnel from ...

    Abstract Background: Persistence of antibodies to SARS-CoV-2 viral infection may depend on several factors and may be related to the severity of disease or to the different symptoms.
    Methods: We evaluated the antibody response to SARS-CoV-2 in personnel from 9 healthcare facilities and an international medical school and its association with individuals' characteristics and COVID-19 symptoms in an observational cohort study. We enrolled 4735 subjects (corresponding to 80% of all personnel) for three time points over a period of 8-10 months. For each participant, we determined the rate of antibody increase or decrease over time in relation to 93 features analyzed in univariate and multivariate analyses through a machine learning approach.
    Results: Here we show in individuals positive for IgG (≥12 AU/mL) at the beginning of the study an increase [
    Conclusions: SARS-CoV-2 infection induces a long lasting antibody response that increases in the first months, particularly in individuals with anosmia/dysgeusia. This may be linked to the lingering of SARS-CoV-2 in the olfactory bulb.
    Language English
    Publishing date 2021-09-17
    Publishing country England
    Document type Journal Article
    ISSN 2730-664X
    ISSN (online) 2730-664X
    DOI 10.1038/s43856-021-00032-0
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Article ; Online: SARS-CoV-2 serology in 4000 health care and administrative staff across seven sites in Lombardy, Italy.

    Sandri, Maria Teresa / Azzolini, Elena / Torri, Valter / Carloni, Sara / Pozzi, Chiara / Salvatici, Michela / Tedeschi, Michele / Castoldi, Massimo / Mantovani, Alberto / Rescigno, Maria

    Scientific reports

    2021  Volume 11, Issue 1, Page(s) 12312

    Abstract: Lombardy is the Italian region most affected by COVID-19. We tested the presence of plasma anti-SARS-CoV-2 IgG antibodies in 3985 employees across 7 healthcare facilities in areas of Lombardy with different exposure to the SARS-CoV-2 epidemic. Subjects ... ...

    Abstract Lombardy is the Italian region most affected by COVID-19. We tested the presence of plasma anti-SARS-CoV-2 IgG antibodies in 3985 employees across 7 healthcare facilities in areas of Lombardy with different exposure to the SARS-CoV-2 epidemic. Subjects filled a questionnaire to self-report on COVID-19 symptoms, comorbidities, smoking, regular or remote working, and the exposure to COVID-infected individuals. We show that the number of individuals exposed to the virus depended on the geographical location of the facility, ranging between 3 and 43%, consistent with the spatial variation of COVID-19 incidence in Lombardy, and correlated with family interactions. We observed a higher prevalence of females than males positive for IgG, however the level of antibodies was similar, suggesting a comparable magnitude of the anti-spike antibody response. IgG positivity among smokers was lower (7.4% vs 13.5%) although without difference in IgG plasma levels. We observed 11.9% of IgG positive asymptomatic individuals and another 23.1% with one or two symptoms. Interestingly, among the IgG positive population, 81.2% of subjects with anosmia/dysgeusia and fever were SARS-CoV-2 infected, indicating that these symptoms are strongly associated to COVID-19. In conclusion, the frequency of IgG positivity and SARS-CoV-2 infection is dependent on the geographical exposure to the virus and primarily to family rather than hospital exposure.
    MeSH term(s) Adaptive Immunity ; Adult ; Aged ; Antibodies, Viral/blood ; Antibodies, Viral/immunology ; COVID-19/blood ; COVID-19/epidemiology ; COVID-19/immunology ; COVID-19 Serological Testing ; Female ; Humans ; Immunoglobulin G/blood ; Immunoglobulin G/immunology ; Incidence ; Italy/epidemiology ; Male ; Middle Aged ; Risk Factors ; SARS-CoV-2/immunology ; SARS-CoV-2/isolation & purification
    Chemical Substances Antibodies, Viral ; Immunoglobulin G
    Language English
    Publishing date 2021-06-10
    Publishing country England
    Document type Clinical Trial ; Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 2615211-3
    ISSN 2045-2322 ; 2045-2322
    ISSN (online) 2045-2322
    ISSN 2045-2322
    DOI 10.1038/s41598-021-91773-4
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  6. Article ; Online: Using biomarkers to predict and to prevent cardiotoxicity of cancer therapy.

    Cardinale, Daniela / Biasillo, Gina / Salvatici, Michela / Sandri, Maria Teresa / Cipolla, Carlo Maria

    Expert review of molecular diagnostics

    2017  Volume 17, Issue 3, Page(s) 245–256

    Abstract: Introduction: Cardiotoxicity is a common complication that may compromise the clinical effectiveness of anticancer therapy. The current standard for monitoring cardiac function detects cardiotoxicity only when a functional impairment has already ... ...

    Abstract Introduction: Cardiotoxicity is a common complication that may compromise the clinical effectiveness of anticancer therapy. The current standard for monitoring cardiac function detects cardiotoxicity only when a functional impairment has already occurred, not allowing for any early preventive strategy. Areas covered: A novel approach, based on the use of biomarkers has recently emerged, resulting in a very effective tool for early, real-time identification, and monitoring of cardiotoxicity. In particular, cardiac troponin elevation during chemotherapy allows to identify patients more prone to develop myocardial dysfunction and cardiac events. In these patients, use of angiotensin-converting enzyme inhibitors, such as enalapril, has shown to be effective in improving clinical outcomes, giving the chance for cardioprotective strategies in a selected population. The authors reviewed the currently available data about the role of biomarkers in this setting. Expert commentary: Early identification of patients at high risk of cardiotoxicity by cardiac biomarkers - in particular troponin - provides a rationale for targeted preventive strategies against cancer therapy-induced left ventricular dysfunction and its associated clinical complications, with the advantage of limiting prophylactic therapy only to a restricted number of patients. Although the major international oncologic societies encourage this approach, some limitations to a routinely use of biomarkers still exist.
    MeSH term(s) Angiotensin-Converting Enzyme Inhibitors/therapeutic use ; Antineoplastic Agents/adverse effects ; Antineoplastic Agents/therapeutic use ; Biomarkers/blood ; Enalapril/therapeutic use ; Heart Diseases/blood ; Heart Diseases/chemically induced ; Heart Diseases/prevention & control ; Humans ; Myocardium/metabolism ; Neoplasms/blood ; Neoplasms/drug therapy ; Troponin C/blood
    Chemical Substances Angiotensin-Converting Enzyme Inhibitors ; Antineoplastic Agents ; Biomarkers ; Troponin C ; Enalapril (69PN84IO1A)
    Language English
    Publishing date 2017-01-29
    Publishing country England
    Document type Journal Article ; Review
    ZDB-ID 2112530-2
    ISSN 1744-8352 ; 1473-7159
    ISSN (online) 1744-8352
    ISSN 1473-7159
    DOI 10.1080/14737159.2017.1283219
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  7. Article ; Online: Association between Cardiac Troponin I and Mortality in Patients with COVID-19

    Michela, Salvatici / Barbara, Barbieri / Cioffi, Sara Maria Giulia / Morenghi, Emanuela / Leone, Francesco Paolo / Maura, Federica / Moriello, Giuseppe / Sandri, Maria Teresa

    Biomarkers

    2020  , Page(s) 1–22

    Keywords Clinical Biochemistry ; Biochemistry ; Health, Toxicology and Mutagenesis ; covid19
    Language English
    Publisher Informa UK Limited
    Publishing country uk
    Document type Article ; Online
    ZDB-ID 1324372-x
    ISSN 1354-750X
    ISSN 1354-750X
    DOI 10.1080/1354750x.2020.1831609
    Database BASE - Bielefeld Academic Search Engine (life sciences selection)

    More links

    Kategorien

  8. Article ; Online: SARS-CoV-2 serology in 4000 health care and administrative staff across seven sites in Lombardy, Italy

    Maria Teresa Sandri / Elena Azzolini / Valter Torri / Sara Carloni / Chiara Pozzi / Michela Salvatici / Michele Tedeschi / Massimo Castoldi / Alberto Mantovani / Maria Rescigno

    Scientific Reports, Vol 11, Iss 1, Pp 1-

    2021  Volume 14

    Abstract: Abstract Lombardy is the Italian region most affected by COVID-19. We tested the presence of plasma anti-SARS-CoV-2 IgG antibodies in 3985 employees across 7 healthcare facilities in areas of Lombardy with different exposure to the SARS-CoV-2 epidemic. ... ...

    Abstract Abstract Lombardy is the Italian region most affected by COVID-19. We tested the presence of plasma anti-SARS-CoV-2 IgG antibodies in 3985 employees across 7 healthcare facilities in areas of Lombardy with different exposure to the SARS-CoV-2 epidemic. Subjects filled a questionnaire to self-report on COVID-19 symptoms, comorbidities, smoking, regular or remote working, and the exposure to COVID-infected individuals. We show that the number of individuals exposed to the virus depended on the geographical location of the facility, ranging between 3 and 43%, consistent with the spatial variation of COVID-19 incidence in Lombardy, and correlated with family interactions. We observed a higher prevalence of females than males positive for IgG, however the level of antibodies was similar, suggesting a comparable magnitude of the anti-spike antibody response. IgG positivity among smokers was lower (7.4% vs 13.5%) although without difference in IgG plasma levels. We observed 11.9% of IgG positive asymptomatic individuals and another 23.1% with one or two symptoms. Interestingly, among the IgG positive population, 81.2% of subjects with anosmia/dysgeusia and fever were SARS-CoV-2 infected, indicating that these symptoms are strongly associated to COVID-19. In conclusion, the frequency of IgG positivity and SARS-CoV-2 infection is dependent on the geographical exposure to the virus and primarily to family rather than hospital exposure.
    Keywords Medicine ; R ; Science ; Q
    Subject code 360
    Language English
    Publishing date 2021-06-01T00:00:00Z
    Publisher Nature Portfolio
    Document type Article ; Online
    Database BASE - Bielefeld Academic Search Engine (life sciences selection)

    More links

    Kategorien

  9. Article ; Online: Squamous cell carcinoma antigen (SCC-Ag) during follow-up of cervical cancer patients: Role in the early diagnosis of recurrence.

    Salvatici, Michela / Achilarre, Maria T / Sandri, Maria T / Boveri, Sara / Vanna, Zanagnolo / Landoni, Fabio

    Gynecologic oncology

    2016  Volume 142, Issue 1, Page(s) 115–119

    Abstract: Objective: The aim of this study was to assess the potential benefit of routine squamous cell carcinoma antigen (SCC-Ag) assessment during follow-up of patients after treatment for early cervical cancer with regard to early diagnosis of cancer ... ...

    Abstract Objective: The aim of this study was to assess the potential benefit of routine squamous cell carcinoma antigen (SCC-Ag) assessment during follow-up of patients after treatment for early cervical cancer with regard to early diagnosis of cancer recurrence before clinical signs and symptoms occur.
    Methods: All clinical, pathological, and serological data of patients referred to the Department of Gynecologic Oncology between July 1999 and June 2014, were retrospectively collected and analyzed. The SCC-Ag levels of 197 patients with diagnosis of stage I or II cervical squamous carcinoma, were performed.
    Results: In the univariate analysis, serum SCC-Ag was not significantly associated with grading (p=0.85), LVSI (p=0.95) and FIGO stage (p=0.83) but it was significantly associated with recurrence of disease (p<0.001). The Cox multivariate analyses showed that serum SCC-Ag level was an independent and statistically significant prognostic factor for OS and PFS. The median time interval between SCC-Ag test and diagnosis of recurrence were 0.3 and 1.8months for positive and negative SCC-Ag groups respectively (p=0.01). Considering patients with recurrence, no significant difference in terms of DFS and OS was found between women with high or low SCC-Ag levels.
    Conclusions: Serum SCC-Ag reflects the response to treatment, and rising antigen levels often precede the clinical detection of recurrent disease, and may lead to early diagnosis. However such an advantage does not seem to improve the cure rate of patients with elevated SCC-Ag levels, most likely due to the lack of curative salvage treatments.
    MeSH term(s) Adult ; Aged ; Antigens, Neoplasm/blood ; Biomarkers, Tumor/blood ; Early Detection of Cancer ; Female ; Follow-Up Studies ; Humans ; Middle Aged ; Neoplasm Recurrence, Local/blood ; Neoplasm Recurrence, Local/pathology ; Neoplasm Staging ; Retrospective Studies ; Serpins/blood ; Uterine Cervical Neoplasms/blood ; Uterine Cervical Neoplasms/pathology ; Young Adult
    Chemical Substances Antigens, Neoplasm ; Biomarkers, Tumor ; Serpins ; squamous cell carcinoma-related antigen
    Language English
    Publishing date 2016
    Publishing country United States
    Document type Journal Article
    ZDB-ID 801461-9
    ISSN 1095-6859 ; 0090-8258
    ISSN (online) 1095-6859
    ISSN 0090-8258
    DOI 10.1016/j.ygyno.2016.04.029
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  10. Article ; Online: Role of biomarkers in cardioncology.

    Cardinale, Daniela / Salvatici, Michela / Sandri, Maria T

    Clinical chemistry and laboratory medicine

    2011  Volume 49, Issue 12, Page(s) 1937–1948

    Abstract: Cardiotoxicity is a serious adverse effect of anticancer drugs, impacting on quality of life and overall survival of cancer patients. According to the current standard for monitoring cardiac function, cardiotoxicity is usually detected only when a ... ...

    Abstract Cardiotoxicity is a serious adverse effect of anticancer drugs, impacting on quality of life and overall survival of cancer patients. According to the current standard for monitoring cardiac function, cardiotoxicity is usually detected only when a functional impairment has already occurred, precluding any chance of preventing its development. Over the last decade, however, a new approach, based on the use of cardiac biomarkers, has emerged, and has proven to be an effective alternative strategy for early detection of subclinical cardiac injury. In particular, the role of troponin I in identifying patients at risk of cardiotoxicity and of angiotensin-converting enzyme inhibitors in preventing left ventricular ejection fraction reduction and late cardiac events represent an effective tool for the prevention of this complication.
    MeSH term(s) Antineoplastic Agents/therapeutic use ; Antineoplastic Agents/toxicity ; Biomarkers/metabolism ; Cardiovascular Diseases/diagnosis ; Cardiovascular Diseases/metabolism ; Cardiovascular Diseases/physiopathology ; Cardiovascular Diseases/prevention & control ; Humans ; Natriuretic Peptides/metabolism ; Neoplasms/diagnosis ; Neoplasms/drug therapy ; Troponin/metabolism
    Chemical Substances Antineoplastic Agents ; Biomarkers ; Natriuretic Peptides ; Troponin
    Language English
    Publishing date 2011-09-06
    Publishing country Germany
    Document type Journal Article ; Review
    ZDB-ID 1418007-8
    ISSN 1437-4331 ; 1434-6621 ; 1437-8523
    ISSN (online) 1437-4331
    ISSN 1434-6621 ; 1437-8523
    DOI 10.1515/CCLM.2011.692
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top